Dry eye medication use and expenditures: Data from the medical expenditure panel survey 2001 to 2006

Cornea

Volumn 31, Issue 12, 2012, Pages 1403-1407

  Galor, Anat ^a,b   Zheng, D Diane ^c   Arheart, Kristopher L ^c   Lam, Byron L ^b   Perez, Victor L ^b   McCollister, Kathryn E ^c   Ocasio, Manuel ^c   McClure, Laura A ^b   Lee, David J ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

dry eye syndrome; expenditures; Medical Expenditure Panel Survey; MEPS

Indexed keywords

CYCLOSPORIN A; SULFACETAMIDE;

ADULT; AQUEOUS TEAR DEFICIENCY; ARTICLE; BLEPHARITIS; DRUG COST; DRY EYE; ECONOMIC ASPECT; EDUCATION; ETHNICITY; FEMALE; HEALTH SURVEY; HIGH SCHOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRY EYE SYNDROMES; FEMALE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84870230391     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823cc0b7     Document Type: Article

References (33)

1. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.
2. Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol. 2001;45(suppl 2):S199-S202.
3. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002;506(pt B):989-998. (Pubitemid 36308292)
4. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610-618. (Pubitemid 32706197)
5. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124:723-728. (Pubitemid 27523148)
6. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268.
7. Bandeen-Roche K, Munoz B, Tielsch JM, et al. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci. 1997;38:2469-2475. (Pubitemid 27492747)
8. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825. (Pubitemid 30395181)
9. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-1119. (Pubitemid 28268339)
10. Chia EM, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003;31:229-232. (Pubitemid 36833372)
11. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol. 1995;233:555-558.
12. Uchino M, Schaumberg DA, Dogru M, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115:1982-1988.
13. Uchino M, Dogru M, Uchino Y, et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol. 2008;146:925-929 e2.
14. Shimmura S, Shimazaki J, Tsubota K. Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea. 1999;18:408-411. (Pubitemid 29294062)
15. Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol. 2005;53:87-91.
16. Lekhanont K, Rojanaporn D, Chuck RS, et al. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25:1162-1167. (Pubitemid 46005853)
17. Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86:1347-1351. (Pubitemid 35408632)
18. Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a U. S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46-50. (Pubitemid 40041177)
19. Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409-415.
20. Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412-1419. (Pubitemid 36842481)
21. Rajagopalan K, Abetz L, Mertzanis P, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health. 2005;8:168-174. (Pubitemid 40525378)
22. Fiscella RG, Lee JT, Walt JG, et al. Utilization characteristics of topical cycolsporine and punctal plugs in a managed care database. Am J Manag Care. 2008;14:S107-S112. (Pubitemid 351656968)
23. Clegg JP, Guest JF, Lehman A, et al. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol. 2006;13:263-274. (Pubitemid 44180007)
24. MEPS Home. Available at: http://www.meps.ahrq.gov/mepsweb/. Accessed June 16, 2011.
25. Data overview, Agency for Healthcare Research and Quality. Available at: http://www.meps.ahrq.gov/mepsweb/data-stats/data-overview.jsp. Accessed June 16, 2011.
26. MEPS HC-113:2007 Full Year Consolidated Data File. Available at: MEPS HC-113:2007 Full Year Consolidated Data File. Available at: http://www.meps. ahrq.gov/mepsweb/data-stats/download-data/pufs/h113/h113doc.shtml. Accessed November 30, 2011.
27. Summary of questionnaire sections. Panel 6 Round 3 and Panel 7 Round 1. Available at: http://www.meps.ahrq.gov/mepsweb/survey-comp/hc-ques-sections.jsp. Accessed June 16, 2011.
28. Pflugfelder SC. Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care. 2008;14:S102-S106. (Pubitemid 351656967)
29. Lam BL, Zheng DD, Davila EP, et al. Trends in glaucoma medication expenditure: medical expenditure panel survey 2001-2006. Arch Ophthalmol. 2011;129:1345-1350.
30. Martin BI, Turner JA, Mirza SK, et al. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006. Spine (Phila Pa 1976). 2009;34:2077-2084.
31. Chen J, Rizzo J. Racial and ethnic disparities in use of psychotherapy: evidence from U. S. national survey data. Psychiatr Serv. 2010;61:364-372.
32. Basu R, Franzini L, Krueger PM, et al. Gender disparities in medical expenditures attributable to hypertension in the United States. Womens Health Issues. 2010;20:114-125.
33. Sutcliffe N, Clarke AE, Taylor R, et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:37-47.